HEMATOLOGY/ONCOLOGY ELECTIVE

PEDIAT 956

Supervised activities include attending pediatric hematology/oncology clinics, evaluating patients in the clinics and attending the weekly pediatric hematology/oncology conferences.

PHMPRAC 678

Addresses practical issues surrounding the optimization of medication use in the treatment of patients with cancer. Practical solutions to the everyday challenges of providing exceptional clinical oncology care in a safe, fiscally responsible manner to optimize clinical outcomes of patients with cancer. Included subjects range across clinical, operational, and practice management issues that affect oncology pharmacy practice. These subjects include: pharmacogenomics, cell therapies, oncology research, survivorship, oral chemotherapy management, hazardous drug handling, value of cancer care, specialty pharmacy and Risk Evaluation and Mitigation Strategy (REMS) processes, and transitions of care. Although focused on oncology patients, offers practical exposure to issues confronting the care of patients with other types of diseases.

MEDICINE 955

Exposure to inpatient and outpatient hepatology practice, focusing on functioning effectively as a consultant. The majority time is spent evaluating new and follow-up consultations in the outpatient and inpatient settings. Oral presentations and effective communication with the patient and the primary service are an essential part of this rotation.

PATH 962

Understanding molecular mechanisms of hematologic disease, and developing a foundation in the principles of relevant molecular assays, is critical to providing appropriate patient care. Topics include bases of neoplastic disorders of the hematopoietic and lymphoid systems, how underlying molecular abnormalities contribute to the pathophysiology of these diseases, and the evolving spectrum of molecular and cytogenetic/FISH testing and other ancillary testing (such as flow cytometry), which are often utilized in the work-up of hematopoietic and lymphoid malignancies. Learn about strengths and weaknesses of these technologies, and how pathologists integrate results of molecular testing with the traditional histologic exam to produce accurate diagnoses and drive clinical decision making. Develop an understanding of how knowing the underlying molecular pathology of a hematopoietic or lymphoid malignancy can inform prognosis and guide therapy.

MEDICINE 919

Care for hospitalized patients on general medicine or hospital medicine services. Admit new patients, round on previously admitted patients, participate in multidisciplinary rounds, and work to transition patients to the next level of care. Evaluate and manage both patients with common inpatient conditions and medically complex patients requiring collaboration with consulting specialties. Complete other patient care related learning activities as assigned by instructors (e.g., literature reviews, presentations on specific topics); these are dependent on the individual student, attending physician, and clinical site.